Risk of hemorrhagic complication associated with ventriculoperitoneal shunt placement in aneurysmal subarachnoid hemorrhage patients on dual antiplatelet therapy

Clinical article

Restricted access

Object

The use of an intracranial stent requires dual antiplatelet therapy to avoid in-stent thrombosis. In this study, the authors sought to investigate whether the use of dual antiplatelet therapy is a risk factor for hemorrhagic complications in patients undergoing permanent ventriculoperitoneal (VP) shunt for hydrocephalus following aneurysmal subarachnoid hemorrhage (aSAH).

Methods

Patients were given 325 mg acetylsalicylic acid and 600 mg clopidogrel during the coil/stent procedure, and they were maintained on dual antiplatelet therapy with acetylsalicylic acid 325 mg daily and clopidogrel 75 mg daily during hospitalization and for 6 weeks posttreatment. Patients underwent placement of VP shunt at a later time during initial hospitalization, usually between 7 and 21 days following aSAH. Postoperative CT scans obtained in each study patient were reviewed for hemorrhages related to placement of the VP shunt.

Results

A total of 206 patients were admitted to the University of Iowa Hospitals and Clinics with aSAH between July 2009 and October 2010. Thirty-seven of these patients were treated with a VP shunt for persistent hydrocephalus. Twelve patients (32%) had previously undergone stent-assisted coiling and were on dual antiplatelet therapy with acetylsalicylic acid and clopidogrel. The remaining 25 patients (68%) had undergone surgical clipping or aneurysm coiling and were not receiving antiplatelet therapy at the time of surgery.

Four cases (10.8%) of new intracranial hemorrhages associated with VP shunt placement were observed. All 4 hemorrhages (33%) occurred in patients on dual antiplatelet therapy for stent-assisted coiling. No new intracranial hemorrhages were observed in patients not receiving dual antiplatelet therapy. The difference in hemorrhagic complications between the 2 groups was statistically significant (4 [33%] of 12 vs 0 of 25, p = 0.0075]). All 4 hemorrhages occurred along the tract of the ventricular catheter. Only 1 hemorrhage (1 [8.3%] of 12) was clinically significant as it resulted in occlusion of the proximal shunt catheter and required revision of the VP shunt. The patient did not suffer any permanent morbidity related to the hemorrhage. The remaining 3 hemorrhages were not clinically significant.

Conclusions

This small clinical series suggests that placement of a VP shunt in patients on dual antiplatelet therapy may be associated with an increased, but low, rate of symptomatic intracranial hemorrhage. It appears that in patients who are poor candidates for open surgical clipping and have aneurysms amenable to stent-assisted coiling, the risk of symptomatic hemorrhage may be an acceptable trade-off for avoiding risks associated with discontinuation of antiplatelet therapy. The authors' results are preliminary, however, and require confirmation in larger studies.

Abbreviations used in this paper:aSAH = aneurysmal subarachnoid hemorrhage; EVD = external ventricular drain; VP = ventriculoperitoneal.

Article Information

Drs. Mahaney and Chalouhi contributed equally to this work.

Address correspondence to: David M. Hasan, M.D., Department of Neurosurgery, University of Iowa Hospitals and Clinics, 200 Hawkins Dr., Iowa City, IA 52242. email: david-hasan@uiowa.edu.

Please include this information when citing this paper: published online June 28, 2013; DOI: 10.3171/2013.5.JNS122494.

© AANS, except where prohibited by US copyright law.

Headings

Figures

  • View in gallery

    Representative postoperative head CT scans of asymptomatic ventricular catheter–associated hemorrhages following VP shunt placement in 3 different patients on dual antiplatelet therapy.

  • View in gallery

    Representative postoperative head CT scan of symptomatic ventricular catheter–associated hemorrhage following VP shunt placement in a patient on dual antiplatelet therapy. The hemorrhage resulted in obstruction of the ventricular catheter, requiring VP shunt revision.

References

1

Amenta PSDalyai RTKung DToporowski AChandela SHasan D: Stent-assisted coiling of wide-necked aneurysms in the setting of acute subarachnoid hemorrhage: experience in 65 patients. Neurosurgery 70:141514292012

2

Benitez RPSilva MTKlem JVeznedaroglu ERosenwasser RH: Endovascular occlusion of wide-necked aneurysms with a new intracranial microstent (Neuroform) and detachable coils. Neurosurgery 54:135913682004

3

Bodily KDCloft HJLanzino GFiorella DJWhite PMKallmes DF: Stent-assisted coiling in acutely ruptured intracranial aneurysms: a qualitative, systematic review of the literature. AJNR Am J Neuroradiol 32:123212362011

4

Chalouhi NDumont ASHasan DTjoumakaris SGonzalez LFStarke RM: Is packing density important in stent-assisted coiling?. Neurosurgery 71:3813872012

5

Chalouhi NJabbour PGonzalez LFDumont ASRosenwasser RStarke RM: Safety and efficacy of endovascular treatment of basilar tip aneurysms by coiling with and without stent assistance: a review of 235 cases. Neurosurgery 71:7857942012

6

Fiorella DAlbuquerque FCHan PMcDougall CG: Preliminary experience using the Neuroform stent for the treatment of cerebral aneurysms. Neurosurgery 54:6172004

7

Gao XLiang GLi ZWei XHong Q: Complications and adverse events associated with Neuroform stent-assisted coiling of wide-neck intracranial aneurysms. Neurol Res 33:8418522011

8

Garell PCMirsky RNoh MDLoftus CMHitchon PWGrady MS: Posterior ventricular catheter burr-hole localizer. Technical note. J Neurosurg 89:1571601998

9

Hoh BLKleinhenz DTChi YYMocco JBarker FG II: Incidence of ventricular shunt placement for hydrocephalus with clipping versus coiling for ruptured and unruptured cerebral aneurysms in the Nationwide Inpatient Sample database: 2002 to 2007. World Neurosurg 76:5485542011

10

Howard MA IIISrinivasan JBevering CGWinn HRGrady MS: A guide to placement of parietooccipital ventricular catheters. Technical note. J Neurosurg 82:3003041995

11

Ingall TJWhisnant JPWiebers DOO'Fallon WM: Has there been a decline in subarachnoid hemorrhage mortality?. Stroke 20:7187241989

12

Kałuza GLJoseph JLee JRRaizner MERaizner AE: Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 35:128812942000

13

Kung DKPoliceni BACapuano AWRossen JDJabbour PMTorner JC: Risk of ventriculostomy-related hemorrhage in patients with acutely ruptured aneurysms treated using stent-assisted coiling. Clinical article. J Neurosurg 114:102110272011

14

Little ASZabramski JMPeterson MGoslar PWWait SDAlbuquerque FC: Ventriculoperitoneal shunting after aneurysmal subarachnoid hemorrhage: analysis of the indications, complications, and outcome with a focus on patients with borderline ventriculomegaly. Neurosurgery 62:6186272008

15

Lodi YMLatorre JGEl-Zammar ZSwarnkar ADeshaies EFessler RD: Stent assisted coiling of the ruptured wide necked intracranial aneurysm. J Neurointerv Surg 4:2812862012

16

Martin ARCruz JPMatouk CCSpears JMarotta TR: The pipeline flow-diverting stent for exclusion of ruptured intracranial aneurysms with difficult morphologies. Neurosurgery 70:1 Suppl Operative21282012

17

McAuliffe WWenderoth JD: Immediate and midterm results following treatment of recently ruptured intracranial aneurysms with the Pipeline embolization device. AJNR Am J Neuroradiol 33:4874932012

18

O'Kelly CJKulkarni AVAustin PCUrbach DWallace MC: Shunt-dependent hydrocephalus after aneurysmal subarachnoid hemorrhage: incidence, predictors, and revision rates. Clinical article. J Neurosurg 111:102910352009

19

Piotin MBlanc RSpelle LMounayer CPiantino RSchmidt PJ: Stent-assisted coiling of intracranial aneurysms: clinical and angiographic results in 216 consecutive aneurysms. Stroke 41:1101152010

20

Sharma AKAjani AEHamwi SMManiar PLakhani SVWaksman R: Major noncardiac surgery following coronary stenting: when is it safe to operate?. Catheter Cardiovasc Interv 63:1411452004

21

Than KDRohatgi PWilson TJGregory Thompson B: Perioperative management of a neurosurgical patient requiring antiplatelet therapy. J Clin Neurosci 19:131613202012

TrendMD

Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 130 130 40
Full Text Views 180 180 17
PDF Downloads 111 111 18
EPUB Downloads 0 0 0

PubMed

Google Scholar